173 related articles for article (PubMed ID: 26815535)
1. MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells.
Zhang JT; Weng ZH; Tsang KS; Tsang LL; Chan HC; Jiang XH
PLoS One; 2016; 11(1):e0148062. PubMed ID: 26815535
[TBL] [Abstract][Full Text] [Related]
2. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
[TBL] [Abstract][Full Text] [Related]
3. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
[TBL] [Abstract][Full Text] [Related]
4. Directed Differentiation of Human Embryonic Stem Cells to Neural Crest Stem Cells, Functional Peripheral Neurons, and Corneal Keratocytes.
Zhu Q; Li M; Yan C; Lu Q; Wei S; Gao R; Yu M; Zou Y; Sriram G; Tong HJ; Hunziker W; Seneviratne CJ; Gong Z; Olsen BR; Cao T
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28762648
[TBL] [Abstract][Full Text] [Related]
5. Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.
Weng Z; Lin J; He J; Gao L; Lin S; Tsang LL; Zhang H; He X; Wang G; Yang X; Zhou H; Zhao H; Li G; Zou L; Jiang X
Neuro Oncol; 2022 Jun; 24(6):872-885. PubMed ID: 34655293
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits proliferation of human neuroblastoma cells without suppression of MycN.
Misawa A; Hosoi H; Tsuchiya K; Sugimoto T
Int J Cancer; 2003 Mar; 104(2):233-7. PubMed ID: 12569580
[TBL] [Abstract][Full Text] [Related]
7. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
Koppen A; Ait-Aissa R; Hopman S; Koster J; Haneveld F; Versteeg R; Valentijn LJ
Cancer Lett; 2007 Oct; 256(2):218-28. PubMed ID: 17643814
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma.
Kerosuo L; Neppala P; Hsin J; Mohlin S; Vieceli FM; Török Z; Laine A; Westermarck J; Bronner ME
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7351-E7360. PubMed ID: 30021854
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
10. Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells.
Mukae K; Takenobu H; Endo Y; Haruta M; Shi T; Satoh S; Ohira M; Funato M; Toguchida J; Osafune K; Nakahata T; Kanda H; Kamijo T
Cancer Sci; 2023 May; 114(5):1898-1911. PubMed ID: 36661413
[TBL] [Abstract][Full Text] [Related]
11. Roles of chromatin remodelers in maintenance mechanisms of multipotency of mouse trunk neural crest cells in the formation of neural crest-derived stem cells.
Fujita K; Ogawa R; Kawawaki S; Ito K
Mech Dev; 2014 Aug; 133():126-45. PubMed ID: 24836203
[TBL] [Abstract][Full Text] [Related]
12. Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis.
Mobley BC; Kwon M; Kraemer BR; Hickman FE; Qiao J; Chung DH; Carter BD
PLoS One; 2015; 10(7):e0133897. PubMed ID: 26222553
[TBL] [Abstract][Full Text] [Related]
13. Expression of the proneural gene encoding Mash1 suppresses MYCN mitotic activity.
Alvarez-Rodríguez R; Pons S
J Cell Sci; 2009 Mar; 122(Pt 5):595-9. PubMed ID: 19208763
[TBL] [Abstract][Full Text] [Related]
14. Notch signaling regulates the differentiation of neural crest from human pluripotent stem cells.
Noisa P; Lund C; Kanduri K; Lund R; Lähdesmäki H; Lahesmaa R; Lundin K; Chokechuwattanalert H; Otonkoski T; Tuuri T; Raivio T
J Cell Sci; 2014 May; 127(Pt 9):2083-94. PubMed ID: 24569875
[TBL] [Abstract][Full Text] [Related]
15. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells.
Jiang X; Gwye Y; McKeown SJ; Bronner-Fraser M; Lutzko C; Lawlor ER
Stem Cells Dev; 2009 Sep; 18(7):1059-70. PubMed ID: 19099373
[TBL] [Abstract][Full Text] [Related]
17. The MYCN oncogene and differentiation in neuroblastoma.
Westermark UK; Wilhelm M; Frenzel A; Henriksson MA
Semin Cancer Biol; 2011 Oct; 21(4):256-66. PubMed ID: 21849159
[TBL] [Abstract][Full Text] [Related]
18. Expression of neural crest markers by human embryonic stem cells: an introductory project.
Bonic A; Poon M; Woods MG; Trounson AO
Aust Orthod J; 2016 Nov; 32(2):175-183. PubMed ID: 29509342
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
[TBL] [Abstract][Full Text] [Related]
20. Sox2: To crest or not to crest?
Mandalos NP; Remboutsika E
Semin Cell Dev Biol; 2017 Mar; 63():43-49. PubMed ID: 27592260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
